2776 - 2800 of 8620 Results
Title
Year
-
OPENTitle: MKK6 binds and regulates expression of Parkinson’s disease‐related protein LRRK2Journal Name: Journal of NeurochemistryPublisher: WileyVol: 112Issue #: 6Start Page: 1593End Page: 1604Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2010.06568.xBest OA location URL: http://doi.org/10.1111/j.1471-4159.2010.06568.xCitation Count: 100
- CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonism2005OPENTitle: CHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonismJournal Name: Journal of NeurochemistryPublisher: WileyVol: 95Issue #: 4Start Page: 974End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2005.03428.xCitation Count: 284
-
OPENTitle: Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologiesJournal Name: Journal of NeurochemistryPublisher: WileyVol: 109Issue #: 2Start Page: 623End Page: 630Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2009.05996.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2009.05996.xCitation Count: 140
- Neurotoxin‐induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress response2012OPENTitle: Neurotoxin‐induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress responseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 6Start Page: 1203End Page: 1210Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07860.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2012.07860.x?download=trueCitation Count: 18
-
OPENTitle: VMAT2 and dopamine neuron loss in a primate model of Parkinson’s diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 1Start Page: 78End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2007.05108.xBest OA location URL: http://doi.org/10.1111/j.1471-4159.2007.05108.xCitation Count: 117
- Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons2009OPENTitle: Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 111Issue #: 5Start Page: 1202End Page: 1212Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2009.06404.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2009.06404.x?download=trueCitation Count: 58
- RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cells2012OPENTitle: RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cellsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 2Start Page: 333End Page: 343Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07780.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3435458Citation Count: 38
-
OPENTitle: Parkin mediates the degradation‐independent ubiquitination of Hsp70Journal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1806End Page: 1819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05261.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4432938Citation Count: 99
- Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s disease2006OPENTitle: Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson’s diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 100Issue #: 6Start Page: 1469End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2006.04333.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8669833Citation Count: 319
- CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s Disease2012OPENTitle: CD4+ Regulatory and Effector/Memory T Cell Subsets Profile Motor Dysfunction in Parkinson’s DiseaseJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 4Start Page: 927End Page: 938Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11481-012-9402-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s11481-012-9402-z.pdfCitation Count: 298
- Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.2006OPENTitle: Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 29End Page: 29Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1742-2094-3-29Best OA location URL: https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/1742-2094-3-29Citation Count: 136
-
OPENTitle: Up-regulation of BDNF in Astrocytes by TNF-α: A Case for the Neuroprotective Role of CytokineJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 1Issue #: 3Start Page: 212End Page: 222Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-006-9020-8Best OA location URL: http://doi.org/10.1007/s11481-006-9020-8Citation Count: 253
-
OPENTitle: Testing NF-κB-based Therapy in Hemiparkinsonian MonkeysJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 3Start Page: 544End Page: 556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-012-9377-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3419771Citation Count: 40
- FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression2009OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 44
-
OPENTitle: Neuronal gene expression correlates of Parkinson's disease with dementiaJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 11Start Page: 1588End Page: 1595Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22184Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2666445Citation Count: 47
-
OPENTitle: Using global statistical tests in long‐term Parkinson's disease clinical trialsJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 12Start Page: 1732End Page: 1739Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22645Best OA location URL: http://doi.org/10.1002/mds.22645Citation Count: 40
-
OPENTitle: Incidental Lewy body disease: Clinical comparison to a control cohortJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 5Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22971Best OA location URL: http://doi.org/10.1002/mds.22971Citation Count: 134
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
-
OPENTitle: The relationship between uric acid levels and Huntington's disease progressionJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 2Start Page: 224End Page: 228Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22907Citation Count: 92
-
OPENTitle: Heart rate changes during freezing of gait in patients with Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 14Start Page: 2346End Page: 2354Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23280Best OA location URL: https://europepmc.org/articles/pmc2964413?pdf=renderCitation Count: 58
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Citation Count: 42
-
OPENTitle: LRRK2 G2019S mutations may be increased in Puerto RicansJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1771End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23632Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3140626Citation Count: 8
-
OPENTitle: Parkinson's disease, cortical dysfunction, and alpha‐synucleinJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 8Start Page: 1436End Page: 1442Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23697Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3154995Citation Count: 23
- Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinations2011OPENTitle: Racial differences may influence the role of cholecystokinin polymorphisms in Parkinson's disease hallucinationsJournal Name: Movement DisordersPublisher: WileyVol: 26Issue #: 9Start Page: 1781End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23655Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3142314Citation Count: 19